Related Experiment Video
Updated: Apr 28, 2026

Author Spotlight: Leptospira DNA Detection in Water for Environmental Analysis and Disease Surveillance
Published on: June 14, 2024
Molecular identification of the ompL1 gene within Leptospira interrogans standard serovars
Mehrangiz Dezhbord1, Majid Esmaelizad, Pejvak Khaki
1Razi Vaccine and Serum Research Institute, Karaj, Iran. asal_dejbord@yahoo.com.
Introduction:
Leptospirosis, caused by infection with pathogenic Leptospira species, is one of the most prevalent zoonotic diseases in the world. Current leptospiral vaccines are mainly multivalent dead whole-cell mixtures made of several local dominant serovars. Therefore, design and construction of an efficient recombinant vaccine for leptospirosis control is very important. OmpL1 is an immunogenic porin protein that could be of special significance in vaccination and serodiagnosis for leptospirosis.
Methodology:
Three strains belonging to pathogenic L. interrogans were analyzed. The specific primers for proliferation of the ompL1 gene were designed. The amplified gene was cloned. In order to investigate the ompL1 nucleotide sequence and homological analysis of this gene, ompL1 genes cloned from standard vaccinal Leptospira serovars prevalent in Iran were sequenced and cloned.
Results:
PCR amplification of the ompL1 gene using the designed primers resulted in a 963 bp ompL1 gene product. The PCR based on the ompL1 gene detected all pathogenic reference serovars of Leptospira spp. tested. Based on alignment and phylogenetic analysis, although the ompL1 nucleotide sequence was slightly different within three vaccinal serovars (100%-85% identity), amino acid alignment of the OmpL1 proteins revealed that there would be inconsiderable difference among them.
Conclusion:
The ompL1 gene of the three isolates was well conserved, differing only by a total of 6 bp and the proteins by 2 amino acids. The cloned gene could be further used for expression and recombinant OmpL1 as an efficient and conserved antigen, and may be a useful vaccine candidate against leptospirosis in our region.
Insights
A conserved OmpL1 gene was identified in pathogenic Leptospira strains, showing minimal variation. This finding supports the development of a recombinant OmpL1 vaccine for leptospirosis control.
Area of Science:
- Veterinary Microbiology
- Infectious Diseases
- Vaccine Development
Background:
- Leptospirosis is a widespread zoonotic disease globally.
- Current vaccines use dead whole-cell mixtures of limited serovars.
- Developing an efficient recombinant vaccine is crucial for leptospirosis control.
Purpose of the Study:
- To analyze the ompL1 gene in pathogenic Leptospira strains.
- To investigate the potential of OmpL1 as a conserved vaccine antigen.
Main Methods:
- PCR amplification and cloning of the ompL1 gene from three pathogenic L. interrogans strains.
- Sequencing and phylogenetic analysis of the ompL1 gene and OmpL1 protein.
Main Results:
- A 963 bp ompL1 gene product was successfully amplified.
- The ompL1 gene detected all tested pathogenic Leptospira serovars.
- OmpL1 nucleotide sequences showed 85%-100% identity, with minimal amino acid differences.
Conclusions:
- The ompL1 gene is highly conserved among the studied Leptospira isolates.
- Recombinant OmpL1 holds promise as an effective and conserved antigen for a leptospirosis vaccine.
Related Concept Videos
Bacterial Phylum Spirochaetes
Modern Molecular Taxonomy

